Five Compounders, One Yardstick: Who Compounds Cleanest in the VMS Universe

Vertical market software lures quality investors with the same promise: many small, tenacious niches, high switching costs, recurring revenues, and a capital allocation system that channels cash from mature businesses into new acquisitions. The blueprint is Constellation Software, and the pattern is so compelling that it is now being copied by dozens of spin-offs and clones.

That is exactly where the trap lies. When five companies all work from the same playbook, it creates the impression that they are interchangeable, equally good compounders. They are not. Constellation is the mature quality anchor, Topicus the cleanest European offshoot, Lumine the smaller compounder with a still-open growth runway, CHAPTERS the young platform with the greatest leverage and the most open flanks — and Asseco the special case that shows why operational strength and shareholder value are two different things. They differ not in the idea but in the execution, and above all in how much of the value creation actually reaches the shareholder and at what price it is bought.

The comparison has gained additional edge since the single-name analyses, because the market has cleaned house brutally over the past twelve months. Constellation itself fell roughly 39 percent from its high, Topicus around 40 percent, Lumine has more than halved from over CA$50 to CA$22.65. The trigger was not an operational collapse but a new worry: whether AI-assisted software development hollows out the moats of the thousand niche providers on which the entire model rests. The central question is therefore no longer just which business is best, but where quality, clean structure and price coincide for the first time in years after this re-pricing — and whether the AI risk is real or overdone.

This article lays the five names side by side and measures them against a single yardstick — the original itself: who compounds cleanest, today and over the next decade?

The Yardstick: What Makes a Clean Compounder

Before comparing five companies, it must be clear what they are measured against. A clean compounder satisfies four conditions simultaneously, not just individually.

First, it needs a business with genuine economic substance — high ROIC on the operating core capital, high switching costs, recurring revenues. Second, it must be able to reinvest capital at returns well above the cost of capital; not only the core business but also the capital paid for acquisitions must earn its keep. Third, the cash generated must actually reach the shareholder of the listed parent and must not leak away through minorities, leverage or holding structures. And fourth — the point where most cases fail — the price must still leave enough margin of safety that normal operational fluctuations do not immediately turn into capital loss.

Conveniently, a living textbook example exists for these four conditions. Constellation Software is not just another name on the list — it is the reference against which the other four are measured.

Constellation: The Living Benchmark

What distinguishes Constellation is not a single headline metric but the simultaneity of all four conditions over decades. On currently employed capital the group earns 19.4 percent ROIC; in the more conservative Leonard logic — measured against all capital ever deployed in M&A — still 16.2 percent. Both figures sit, with a spread of roughly 9.6 to 12.9 percentage points, far above the cost of capital.

Even more revealing is the third lens: strip out the acquired intangibles entirely and the invested capital of the core business turns negative. Customers pay in advance; negative working capital co-finances the operation. Economically that means operating capital efficiency is practically infinite, and the real source of value is not the operation but the decision about what happens to the surplus cash. That is the pure form of the compounder model that the other four only approximate.

Remarkably, the machine has not stalled at roughly CA$63 billion of market value. Free cash flow grew at around 23 percent annually over eight years, with only a single, marginal down year. This consistency through a full cycle including the rate shock is the strongest empirical argument against the AI bear: so far, nothing has slowed the cash generation.

That is precisely what makes Constellation the useful anchor. Every question to the four offshoots boils down to: how close do you come to the original — on quality, on cleanliness, on price? And Constellation itself supplies the humility with which the whole field should be viewed: even the best business is at best fairly priced at today's level.

The Five at a Glance

The table reveals a pattern that runs through the entire comparison: operational quality is abundant in the VMS universe. What is scarce are clean capital structures and attractive prices — and after the sell-off, that second point shifts in buyers' favor for the first time in years.

Business Quality: Constellation and Topicus Lead

On pure business quality, the original and its European offshoot lead. Constellation delivers 16.2 percent returns in the Leonard logic on all M&A capital ever deployed — and a core business that ties up so little capital it is arithmetically capital-negative. Topicus combines a high share of recurring revenue at 71 percent with an operating ROIC of 20.4 percent after Asseco adjustment, and cash generation so robust it renders the reported earnings line almost meaningless. Free cash flow in 2025 stood at roughly 965 percent of reported profit and grew at around 26 percent annually from 2018 to 2025 without a single down year. That the Leonard ROIC of 16.9 percent sits below the operating core is a reminder that on a total-capital basis — including Asseco — some shine is lost.

Asseco is the interesting paradox of the quintet: on operating core capital, the group earns the highest core return of all five at 30.0 percent. Unfortunately, that high core return does the shareholder little good because it is diluted on the way up — including the purchase price paid, ROIC falls to 12.9 percent, and a large part of what remains belongs to minorities.

Lumine and CHAPTERS are the early-stage representatives. Both have the right DNA — specialized niches, recurring revenues, decentralized leadership — but on a smaller base and a shorter track record. At CHAPTERS, German-GAAP (HGB) accounting with its mandatory goodwill amortization completely obscures the economic reality of the ~19 percent core business: reported EBIT is negative while free cash flow is clearly positive.

Capital Allocation: Where the Gap Between Core and Purchase Price Decides

The most interesting metric is not the core business ROIC but the difference between core ROIC and the ROIC on the purchase price paid. It shows whether a compounder deploys capital with discipline or extravagance.

Constellation and Topicus show the healthiest profile here. At Constellation the proof has long been delivered: even in the conservative Leonard calculation, which counts every dollar ever put into M&A, ROIC stands at 16.2 percent — a spread of roughly 9.6 percentage points above the cost of capital, consistent over decades. Topicus follows with a Leonard ROIC of 16.9 percent; the gap to the operating core is moderate, the level stays above the cost of capital. That is the mechanics of an allocator who pays for quality but does not overpay.

Lumine is the special case of this table — not because discipline is lacking, but because the proof is not yet measurable. Since the 2023 spin-off, the standalone history is too short and the balance sheet too much in motion from the large acquisitions (most recently Synchronoss) to compute a reliable Leonard ROIC on capital paid. The indications — Constellation DNA in the playbook, clean cash flow conversion, moderate leverage of 0.53x — point to discipline. But that is exactly the difference between indication and proof: at Constellation and Topicus the acquisition return is measured; at Lumine it is, so far, an advance of trust. That belongs to the reasoning why the 12x premium is harder to justify.

Asseco reveals the opposite pattern: an excellent core business (30.0 percent) pushed down to 12.9 percent on capital paid by expensive historical acquisitions. CHAPTERS is the sharpest case — on the purchase price paid, ROIC falls to around 4 percent, below the WACC of 7.9 percent. As long as that figure sits below the cost of capital, every further debt-funded acquisition arithmetically widens the gap, especially as CHAPTERS is, at 3.87x net debt/EBITDA, the most levered of the five.

Who Owns the Profit? The Asseco Trap

This is where the field separates most clearly. A compounder can be operationally excellent — if the profit generated does not reach the shareholder of the listed parent, the business quality is worth only half as much to the investor.

That is the central reason why Asseco, despite the highest core ROIC and the optically lowest multiple, is not a clean compounder. The relevant cash flow is not the consolidated group cash flow but the parent-attributable cash flow after minority leakage — and that is far more ordinary than the headline picture.

CHAPTERS suffers from the same problem in milder form. Minorities account for roughly 29 percent of group equity, and the largest EBITDA block is only 61.7 percent owned by CHG. At Constellation, Topicus and Lumine this leakage is smallest — owner cash flow is most cleanly attributable there.

The Earnings Line Lies — for Three of Them, in Different Ways

A recurring motif: for these companies, reported net income is a poor guide. The reasons differ.

At Topicus, a EUR 221.7 million write-down on acquisition cost related to the Asseco accounting pushed 2025 earnings from 92 to 42 million euros — an accounting effect, not an operational deterioration. At Asseco the effect works in the opposite direction: reported group earnings jumped to PLN 3,628 million in 2025, but the bulk stems from the sale of the Sapiens majority stake — a one-off. At CHAPTERS, HGB accounting forces straight-line goodwill amortization that produces negative EBIT while free cash flow remained positive and compounds at 64 percent CAGR. The reported LTM ROIC of −1.9 percent on TIKR is exactly this artifact.

The lesson for all five: anyone valuing these companies on simple earnings multiples is analyzing the accounting, not the business. Cash flow and ROIC on the right capital base are the more reliable lenses. It is no coincidence that the NTM MC/FCF multiple — the price on free cash flow — is the most meaningful valuation line in the overview table.

The Shared Risk: AI Versus the Moats

However different the five are in structure and maturity — they share one risk, and it is the real reason for the sector-wide sell-off. The VMS model rests on thousands of small niche providers being protected by high switching costs, deep process integration and a lack of alternatives. It is precisely these moats the market has been questioning since 2026: if AI-assisted software development lowers the cost of replacing or rebuilding a niche solution, the protection that carries pricing power and customer retention shrinks.

This risk does not hit the five equally. Constellation and Topicus are most broadly insured through diversification across thousands and hundreds of end markets respectively — no single disrupted niche moves the whole. Lumine is concentrated on the communications and media industry and thus more focused in its exposure. Asseco sits in regulated, often governmental end markets where replacements are slow and political — which paradoxically protects. CHAPTERS, in turn, is trying to use AI offensively as an opportunity by converting the structured data of its OpCos into new products.

The empirical counterargument so far comes from cash generation itself: through the full rate cycle and the ongoing AI hype, free cash flow at Constellation, Topicus and Lumine has kept growing. Nothing has slowed the machine yet. That does not make the risk smaller, but it tempers the speed at which a moat-erosion thesis would have to show up in the numbers. For the investor it is the decisive open question — and the reason even the original is merely fair, not cheap, today.

The Tokenization Test: Five Questions, Five Very Different Answers

The AI risk can be framed more precisely than with the blanket question "are the moats eroding?". The software sector is simultaneously undergoing a concrete, measurable upheaval: the shift from per-seat pricing to token, usage and outcome models — IDC expects roughly 70 percent of vendors to abandon pure seat pricing by 2028 (full dossier here). The dossier yields a checklist of five questions applicable to any software name. Applied to the five compounders, it shows: the market punished the group uniformly — but the risk is anything but uniformly distributed.

Three findings stand out. First: Constellation and Topicus pass the test almost completely — their pricing metrics were never the seat for routine knowledge work, their maintenance revenues are committed rather than consumption-dependent, and both can layer AI capabilities as usage-priced modules on top of a captive customer base without ever having to undergo the costly pricing migration facing horizontal SaaS vendors. That is the offensive reading lost in the blanket AI discount.

Second: Asseco scores surprisingly well on this axis — regulated, governmental end markets are the most deflation-resistant moat form there is. That sharpens the finding from the structure chapter: the 5.85x multiple really is a pure minority discount, not hidden AI risk. Whoever buys the discount buys the structure, not the disruption.

Third: CHAPTERS collects the most open flags in the field — not because anything negative is proven, but because the decisive disclosures are missing. Which license metrics do the top OpCos use (German Mittelstand software is traditionally licensed per workstation — the German translation of the seat)? What is the ARR share? And will the AI modules of the Momentum initiative be priced separately on usage, or bundled into existing maintenance flat fees? Three questions for the next annual meeting — at 23.3x EV/EBITDA, not even the pricing resilience the multiple already assumes is verifiable.

Valuation: The Sell-Off Changes the Picture

This is where the most has changed since the single-name analyses. Back then the verdict for nearly all names was: good quality, but no margin of safety. After a year in which the entire segment lost 25 to 40 percent, that statement needs differentiating.

The real surprise is relative valuation. Topicus trades at 10.65x NTM EV/EBITDA — now cheaper than Constellation (11.97x) and cheaper than Lumine (12.03x) — even though it is the more mature and cleaner business than Lumine. After the 40 percent decline, a margin of safety has emerged at Topicus for the first time in years, at least partly compensating for the complexity added by Asseco.

Lumine is the other side of the same coin: despite the halving of its share price it remains, at 12.03x, the most expensive of the three "clean" businesses and thus still carries a premium that is harder to justify after the discovery discount has gone. Asseco is by far the cheapest on multiples at 5.85x EV/EBITDA and a 6.1 percent dividend yield — but that is the structural discount, not a substance rebate. And CHAPTERS, at 23.29x EV/EBITDA, is by far the most expensive name in the field; even after a 26 percent share price decline, the market prices in a successful compounder that still has to grow into its valuation.

Two Questions, Two Rankings

Here it pays to draw a distinction the market likes to blur. These five names do not answer the same investor question. Whoever seeks the safest compounder arrives at a different order than whoever seeks the largest possible multiplication. Both questions are legitimate — but they lead to different stocks, and most mistakes happen where they get mixed.

Question one: Who is the safest, cleanest compounder? Here the simultaneity of quality, clean structure and a sensible price counts.

The answer to this question is calm and clear. Constellation is the best business with the burden of proof already met — but even after the crash, without a margin of safety, with a fair value roughly 8 percent below the price. Topicus is the cleanest European quality name and, after a 40 percent decline at 10.65x EV/EBITDA, the name with the best combination of quality, structure and price. Lumine has the same clean mechanics but remains, at 12.03x, the most expensive of the three clear businesses. Asseco and CHAPTERS fall behind on this axis — not because the operating business is weak, but because at Asseco almost half the profit goes to minorities and CHAPTERS earns less than its cost of capital on the purchase price paid.

Question two: Which stock could multiply the most from today's point? Here the order flips — but not as uncritically as it first tempts.

In theory, smaller, not-yet-fully-proven compounders have the longest reinvestment runway and, if successful, the strongest leverage. By that logic CHAPTERS moves to the front, Lumine right behind. Both are small enough that individual successful acquisitions can visibly change the profile — an asymmetry that the mature Constellation structurally can no longer offer.

But this is exactly where discipline is required. CHAPTERS already trades at 23.3x EV/EBITDA — the richest multiple in the field. The return source "multiple expansion" is weakest precisely where the multiple is already highest. CHAPTERS' upside therefore does not hang on a re-rating but on the company growing into its valuation: margins normalizing, ROIC incl. breaking through the WACC threshold, and the interest burden remaining manageable. That is possible, but it is a bet on execution, not on a mispricing. Lumine is the more measured version of the same idea: smaller than Topicus, with a more open growth runway, but without the rich multiple and without CHAPTERS' leverage question marks.

The real investment case therefore begins with being clear about one's own question. Those seeking stability hold Constellation as the anchor and use Topicus as the relatively most attractive entry. Those deliberately trading uncertainty for potential look at Lumine and — eyes open to the conditions — at CHAPTERS. Asseco remains the special case in both: operationally strong, but interesting as a stock only once the minority share structurally declines.

Bear Versus Bull for the Overall Case

Conclusion

Five companies, one playbook, five very different realities. The popular assumption that every Constellation clone is automatically a good compounder does not survive scrutiny. Operational quality is abundant in the VMS universe — Constellation, Topicus and Asseco even show excellent core returns. But quality alone does not make a good stock, and above all it does not make the same stock.

The case is decided on the levels above, and the most honest answer depends on the question being asked. Those seeking the safest, cleanest compounder end up with Constellation as the anchor and Topicus as the relatively most attractive entry — both carried by proven quality, both at fair rather than gifted prices. Those deliberately trading more uncertainty for more potential look at Lumine and CHAPTERS — with CHAPTERS combining the largest theoretical upside with the richest multiple and the highest number of conditions still to be proven. Asseco remains the instructive special case: a good business whose value to the shareholder hangs on the ownership structure, not on operational strength.

Above it all stands the shared AI risk that explains why even the best business in the field is merely fair, not cheap, today. The tokenization test shows, however, that this risk is not evenly distributed: Constellation and Topicus structurally sit closer to the beneficiary side of the pricing shift, while at CHAPTERS resilience remains unproven for lack of disclosure. The soberest conclusion therefore reads: Constellation is the best business. Topicus is the most balanced stock. Lumine is the most interesting smaller quality bet. CHAPTERS is the name with the greatest leverage — and the most conditions. Patience in this universe is not a sacrifice of returns. It is part of the returns — and after the re-pricing, it is needed a little less in one place than it was a year ago.